Complement Therapeutics
Latest round
- Series A
Last raised
- Apr 2023
Total raised
- $85M
Investors
- 7
About Complement Therapeutics
Based in London, UK, and founded in 2020 by Simon J.a. CTx operates as a biotechnology company that conducts research and develops novel therapeutic approaches to address needs in diseases related to complement dysregulation through gene therapies and protein-based approaches. As of February 2022, Rafiq Hasan is the CEO of Complement Therapeutics Ltd. Complement Therapeutics Ltd is developing the next generation of complement medicines by processing new complement system insights into innovative treatments for complement-related diseases, such as age-related macular degeneration. The company has also developed a complement precision medicine (CPM) platform, a novel mass spectrometry platform that enables the measurement of more than 30 complement proteins from a systemic blood sample.
Who invested in Complement Therapeutics
7 investors across 2 rounds
See all investors in Complement Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Complement Therapeutics
Who invested in Complement Therapeutics?
Complement Therapeutics has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Complement Therapeutics raised?
Complement Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Complement Therapeutics last raise money?
Complement Therapeutics's most recent round on record is a Series A, in Apr 2023.
What does Complement Therapeutics do?
Based in London, UK, and founded in 2020 by Simon J.
Where is Complement Therapeutics headquartered?
Complement Therapeutics is headquartered in London, UK.
Which VCs invest in companies like Complement Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Complement Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Complement Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.